KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Assets Average (2016 - 2025)

Historic Assets Average for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $109.1 billion.

  • Novartis Ag's Assets Average rose 605.92% to $109.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $109.1 billion, marking a year-over-year increase of 605.92%. This contributed to the annual value of $106.6 billion for FY2025, which is 544.24% up from last year.
  • Novartis Ag's Assets Average amounted to $109.1 billion in Q4 2025, which was up 605.92% from $105.8 billion recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Assets Average peaked at $128.5 billion during Q1 2022, and registered a low of $95.9 billion during Q2 2024.
  • Moreover, its 5-year median value for Assets Average was $111.7 billion (2023), whereas its average is $112.4 billion.
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 1541.83% in 2024, then soared by 651.43% in 2025.
  • Novartis Ag's Assets Average (Quarter) stood at $126.5 billion in 2021, then fell by 6.75% to $118.0 billion in 2022, then fell by 9.87% to $106.3 billion in 2023, then fell by 3.23% to $102.9 billion in 2024, then rose by 6.06% to $109.1 billion in 2025.
  • Its last three reported values are $109.1 billion in Q4 2025, $105.8 billion for Q3 2025, and $102.2 billion during Q2 2025.